Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma.
Autor: | Zhou, Yinghong, Dong, Xiaofeng, Xiu, Peng, Wang, Xin, Yang, Jianrong, Li, Lei, Li, Zhongchao, Sun, Pengfei, Shi, Xuetao, Zhong, Jingtao |
---|---|
Zdroj: | Oxidative Medicine & Cellular Longevity; 3/24/2020, p1-15, 15p |
Databáze: | Complementary Index |
Externí odkaz: |